Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Contact Us Sitemap Sign In Register
Link to Homepage About AHAF
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when submission deadlines are announced please click on the link below.

Sign up for new RFP announcements and submission deadline notifications.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research funding through the American Health Assistance Foundation (www.ahaf.org). Please follow instructions on the notification emails for removal requests.
 
AHAF Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

  

Alzheimer's Disease Research - Current Award

Dr. Mathias Mathias Lösche

Mathias Lösche, Ph.D.

Carnegie Mellon University
Pittsburgh, PA

Title: Lipid Bilayer Reorganization by Amyloid-beta Oligomers
Non-Technical Title: How do misfolded peptide aggregates affect neuronal cell membranes?

Duration: April 1, 2008 - March 31, 2010
Award Type: Pilot
Award Amount: $149,940


Summary:

This team will use synthetic models of neuronal cell membranes, to study how ABeta interacts with these membranes. The results of these studies will be insight into the damaging effects of ABeta and how this effect varies with membrane lipid composition.

Details:

How do misfolded peptide aggregates interact with lipid membranes? More specifically, how do amyloid-Beta (ABeta) oligomers affect neuronal cell membranes? ABeta is a 40 or 42 amino acids long fragment of the amyloid precursor protein APP which has long been implicated t play a crucial role in the etiology of Alzheimer's Disease (AD) . A progressively larger body of evidence has recently accrued that the toxic form of ABeta is a soluble aggregation of the protein, and that such ABeta 'oligomers' interact strongly with cell membranes. Using novel synthetic membrane models, we have developed suitable experimental tools to address the questions posed above in structural, functional and dynamic terms on the molecular level. In this ADR Pilot Grant award, we will to study the response of such synthetic membranes to ABeta oligomers as a function of membrane composition. We are particularly interested in membrane compositions that mimic the lipid characteristics of neuronal cell membranes in order to investigate whether ABeta oligomers interact with such membranes strongly. The proposed research may have implications for a molecular-scale understanding of the damage that ABeta oligomers inflict on neuronal membranes and may in the long run also help to devise synthetic strategies for the early detection of ABeta oligomers in patient samples. The specific aims of this research are to investigate the interaction of ABeta oligomers with synthetic lipid membranes of well-defined compositions and to correlate the structural, functional and dynamic response of such membranes to ABeta with the aggregation state of the peptide.